The post Toyota Prado-targeting sub-$80,000 price for 2026 Denza B5 large off-road SUV appeared first on Drive. Denza ...

The listing largely matched expectations with the grey market, with Advance Agrolife’s grey market premium (GMP) standing at about 15 per cent just before its debut. The total market capitalisation of ...

On October 1, Toyota announced a compliance recall involving around 394,000 vehicles in the United States. The action affects certain Toyota Tundra and Tundra Hybrid models from 2022 to 2025, as well ...

The shares of Sheel Biotech made a strong debut on stock markets on October 8, listing at Rs 91 apiece on the NSE Emerge platform. This marks a premium of around 44.44 percent over the IPO price of Rs ...

Central government has updated rates for nearly 2,000 CGHS tests and procedures. This revision, effective October 13, aims to help over 40 lakh beneficiaries access treatment at top hospitals. Some ...

Consumers planning to buy gold or silver should keep a few key points in mind to ensure value and authenticity. Always check for BIS Hallmark certification before making a purchase, and compare rates ...

Toyota CEO says the introduction of the ad valorem tax was the beginning of the problem, as it does not make sense in 2025. It is no secret that car prices have skyrocketed in recent years. 30 years ...

The shares of Manas Polymers and Energies made a bumper market debut on October 6, listing at Rs 153.90 apiece on the NSE Emerge platform. This marks a premium of 90 percent over the SME IPO price of ...

The on-road price of the Toyota Innova Hycross in Armoor starts at Rs. 21.15 lakh (ex-showroom: 18,15,700 + RTO: 1,99,727 + Insurance: 99,241), and the EMI starts at Rs. 34,720 while the Innova ...

The on-road price of the Toyota Innova Crysta in Darbhanga starts at Rs. 21.72 lakh (ex-showroom: 18,65,700 + RTO: 2,05,227 + Insurance: 1,01,169), and the EMI starts at Rs. 35,677 while the Innova ...

Repatha is now available for a monthly cash price of $239, through AmgenNow and GoodRx. Repatha (evolucumab) is now avaliable at a discounted cash price through Amgen's new direct-to-patient program, ...